drugset / Trial / NCT03734302
The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects
NaSingle-groupOpen-labelOther
Summary
This study is a single-center, open-label study evaluating the pharmacokinetics and safety of multiple dose oral administration of Brexpiprazole (1 mg) tablets in Chinese healthy subject.10 healthy adult subjects will be enrolled in this study. A single dose (Brexpiprazole 1 mg) group is set and the test drug will be administered for 14 consecutive days.
Timeline
- Start
- 2019-04-24
- Primary completion
- 2020-06-10
- Completion
- 2020-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brexpiprazole | Small molecule | 1 mg | Oral |
Indications
No indication recorded.